Check Before You Invest : Coral Laboratories Ltd

Snapshot

Q.1 Which industry/sub-sector does Coral Laboratories Ltd belong to?

Coral Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Coral Laboratories Ltd a good quality company?

Coral Laboratories Ltd is a average quality company, based on a somewhat consistent 10-year financial track record.

Q.3 Is Coral Laboratories Ltd undervalued or overvalued?

Coral Laboratories Ltd appears Fair, as its key valuation ratios are in line with their past averages.

Q.4 Is Coral Laboratories Ltd a good buy now?

Coral Laboratories Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Coral Laboratories Ltd?

Coral Laboratories Ltd revenue growth is 37.5% for FY-2025, which is above its 5-year CAGR of 10.26%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Coral Laboratories Ltd?

Coral Laboratories Ltd Return on capital employed is 17.04% for FY-2025, which is above its 5-year historical median of 12.48%. The current ROCE is above its estimated weighted average cost of capital (WACC) of 14%, indicating value creation.

Q.3 Return on Asset of Coral Laboratories Ltd?

Coral Laboratories Ltd Return on Asset is 11.1%, which is above its 5-year historical median of 8.31%, indicating improved asset utilization efficiency.

Q.4 Return on Equity (ROE) of Coral Laboratories Ltd?

Coral Laboratories Ltd Return on equity is 12.76% for FY-2025, which is above its 5-year historical median of 9.5%, indicating the business is making better use of its shareholders capital.

Q.5 Cash conversion cycle of Coral Laboratories Ltd?

Coral Laboratories Ltd Cash conversion cycle is 92 days, below its 5-year historical median of 146 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.53	0.44
ROE	12.76	9.5
ROCE	17.04	12.48
Cash Conversion Cycle	92 days	146 days

Q.6 Gross Profit margin of Coral Laboratories Ltd?

Coral Laboratories Ltd Gross profit margin which is the profit after deduction of direct costs, is 30.7% for FY-2025, which is above its 5-year median of 20.3%, indicating increasing margins.

Q.7 Operating Profit Margin of Coral Laboratories Ltd?

Coral Laboratories Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 22.82% for FY-2025, which is above its 5-year median of 16.41% indicating increasing margins.

Q.8 Net Profit Margin of Coral Laboratories Ltd?

Coral Laboratories Ltd Net Profit Margin is 21% for FY-2025, is above with its 5-year median of 14.04%, indicating increasing margins.

	Current Level	5-year Historic Median
Gross Profit Margin	30.7	20.3
Operating Profit Margin	22.82	16.41
Net Profit Margin	21	14.04

Q.9 Debt to Equity ratio of Coral Laboratories Ltd?

Coral Laboratories Ltd Debt-to-Equity ratio is 0.02, which is lower with the industry average of 0.27, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Coral Laboratories Ltd?

Coral Laboratories Ltd Debt to cash flow from operations is -2.91, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Coral Laboratories Ltd?

Promoters hold 71.51% of the Coral Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Coral Laboratories Ltd vs industry peers?

Coral Laboratories Ltd revenue CAGR is 10.26%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	37.5	8.3
Gross Profit Growth	52.2	14.7
Operating Profit Growth	62.5	11.4
Net Profit Growth	50	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.53	0.81
ROE	12.76	9.49
ROCE	17.04	11.91
Cash Conversion Cycle (days)	91.61	85

Valuation & price assessment

Q.1 Stock return of Coral Laboratories Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of -0.2% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	-0.2%	1.8%	17.8%	-35.1%

Q.3 Valuation ratios of Coral Laboratories Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	10.86	11.64	31.09
Price to Book	0.7	0.77	2.85
Price to Sales	1.73	1.63	2.79
EV to EBITDA	3.7	5.41	15.87

Check more companies

6. Wockhardt

7. Pfizer

8. Piramal Pharma

9. Acutaas Chemicals

10. Astrazeneca Pharma I

Check trending companies

1. Honasa Consumer Ltd.

2. Colgate-Palmolive (India) Ltd.

3. Godrej Consumer Products Ltd.

4. Emami Ltd.

5. Dabur India Ltd.